Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Valneva SE
  6. News
  7. Summary
    VLA   FR0004056851

VALNEVA SE

(VLA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ValnevaSE Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 Vaccine VLA2001

12/08/2021 | 01:00am EST

ValnevaSE announced the signing of an advance purchase agreement with the Kingdom of Bahrain for the supply of one million doses of the Company’s inactivated COVID-19 vaccine candidate VLA2001. This is the second purchase agreement Valneva has secured for VLA2001 since reporting positive data for its Phase 3 clinical trial Cov-Compare. Valneva has initiated a rolling submission process with the Bahraini National Health Regulatory Authority (NHRA).


ę S&P Capital IQ 2021
All news about VALNEVA SE
01/20Top Premarket Decliners
MT
01/20EUROPEAN MIDDAY BRIEFING - Stocks Down After Mixed Asia Trading, US Fall
DJ
01/20Valneva Gains 20% as COVID-19 Jab Shows Effect Against Omicron in Preliminary Studies
MT
01/20VALNEVA : Kepler Cheuvreux reiterates its Buy rating
MD
01/19Valneva COVID-19 Jab Shows Effect Against Omicron After Three Doses in Phase 1/2 Study
MT
01/19Valneva's Vaccine Candidate Neutralizes Omicron Variant in Early Studies; Shares Surge
MT
01/19VALNEVA : Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant - For..
PU
01/19Latest on the worldwide spread of the coronavirus
RE
01/19Valneva says early studies show COVID-19 vaccine effective against Omicron
RE
01/19Valneva says early studies show COVID-19 vaccine effective against Omicron
RE
More news
Analyst Recommendations on VALNEVA SE
More recommendations
Financials
Sales 2021 103 M 117 M 117 M
Net income 2021 -146 M -165 M -165 M
Net cash 2021 148 M 168 M 168 M
P/E ratio 2021 -10,8x
Yield 2021 -
Capitalization 1 647 M 1 868 M 1 866 M
EV / Sales 2021 14,5x
EV / Sales 2022 2,64x
Nbr of Employees 700
Free-Float 76,5%
Chart VALNEVA SE
Duration : Period :
Valneva SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VALNEVA SE
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 15,66 €
Average target price 22,38 €
Spread / Average Target 42,9%
EPS Revisions
Managers and Directors
Thomas Lingelbach Co-President & Chief Executive Officer
Franck Charles Marie Grimaud Co-President & Chief Business Officer
Peter Buhler Chief Financial Officer & Director
FrÚdÚric Grimaud Chairman-Supervisory Board
Michael M÷hlen Vice President-Technical Development
Sector and Competitors
1st jan.Capi. (M$)
VALNEVA SE-36.08%1 868
MODERNA, INC.-36.98%64 900
LONZA GROUP AG-15.65%52 307
IQVIA HOLDINGS INC.-14.60%46 031
SEAGEN INC.-17.50%23 323
ICON PUBLIC LIMITED COMPANY-18.65%20 508